China adds 91 new drugs to national insurance, aiming to cut patient costs by $7 billion.

China plans to make 91 new drugs more affordable by adding them to the national medical insurance scheme, expected to reduce patient costs by 50 billion yuan ($7 billion). This move expands the total number of covered medications to 3,159, improving access to treatments for chronic and rare diseases. The government also lowered prices through bulk procurement and negotiations, making cochlear implants and peripheral vascular stents more affordable. These efforts have benefited over 830 million recipients and saved over 880 billion yuan in patient expenditures.

January 01, 2025
4 Articles